Clinical trials
Phase 4 Atrial Fibrillation trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 6 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Unknown status | 10 |
| Terminated | 6 |
| Recruiting | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Deutsches Herzzentrum Muenchen | 8 |
| Medtronic BRC | 4 |
| Medtronic Cardiac Rhythm and Heart Failure | 4 |
| Charite University, Berlin, Germany | 3 |
| Population Health Research Institute | 3 |
| Atrial Fibrillation Network | 2 |
| Biotronik SE & Co. KG | 2 |
| Sanofi | 2 |
| Abbott Medical Devices | 1 |
| Biotronik, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atrial Fibrillation | 50 |
| Heart Failure | 7 |
| Stroke | 7 |
| Acute Coronary Syndrome | 3 |
| Coronary Artery Disease | 2 |
| Sick Sinus Syndrome | 2 |
| Atherosclerosis | 1 |
| Atrial Flutter | 1 |
| Atrioventricular Block | 1 |
| Bradycardia | 1 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.